Flexion Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Flexion Therapeutics Inc announces closing of initial public offering
Flexion Therapeutics Inc:Says the closing of its initial public offering of 5,750,000 shares of its common stock at an initial public offering price of $13.00 per share.Says it offered all of the shares of common stock.Says the aggregate net proceeds to Flexion, after underwriting discounts and commissions and estimated offering expenses, are expected to be about $67.3 mln.Says BMO Capital Markets and Wells Fargo Securities, LLC acted as joint book-running managers.Says Needham & Company and Janney Montgomery Scott acted as co-managers.
Latest Developments for Flexion Therapeutics Inc
Latest Key Developments in Biotechnology
- Share this
- Digg this